Bone histomorphometry and in vitro differentiation of bone marrow cells into osteoclasts revealed an increased osteoclastogenesis due to the Hras G12V mutation, indicating deregulated osteoclastogenesis as a major contributor to the bone loss in CS. The gene discussed is HRAS; the disease is Cowden syndrome 1.